Grant Details

General Overview

Grant Information

Grant name: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research

Funding organization: National Institutes of Health (NIH), National Cancer Institute (NCI)

Total funding amount: $1,000,000

Duration: Maximum project period of 3 years

Primary objective: To support the development of innovative technologies for biospecimen handling in cancer research

Significance: Aims to enhance research in cancer biology, early detection, and treatment

Grant frequency: One-time funding opportunity

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions of Higher Education

Private Institutions of Higher Education

Nonprofits (with and without 501(c)(3) status)

For-Profit Organizations (including Small Businesses)

Local, State, County, City or Township Governments

Indian/Native American Tribal Governments (both recognized and non-recognized)

Federal Government Agencies

Foreign Organizations

Specific Qualifications

Organizations must complete registrations with SAM, eRA Commons, and Grants.gov prior to application submission.

Scope and Focus

Primary Focus Areas

Development of innovative technologies for biospecimen collection, handling, processing, preservation, and storage.

Addressing cancer health disparities and improving the quality of biospecimens for research.

Expected Outcomes

Technologies should enhance research capabilities and address unmet needs in cancer research.

Technical Details

Technical Expertise Requirements

Applicants must demonstrate the capability to develop innovative biospecimen technologies.

Financial Structure

Budget Information

Maximum budget per application: $150,000 per year

Total project budget may not exceed $450,000 over 3 years.

Timeline and Implementation

Key Dates

Application due date: October 3, 2025

Earliest start date: April 4, 2025

Compliance and Requirements

Regulatory Compliance

All applications must comply with NIH Grants Policy Statement.

Application Process

Submission Instructions

Applications must be submitted electronically through Grants.gov.

A letter of intent is encouraged but not required.

Grant Details

cancer biospecimen healthcare research innovation technology clinical research health disparities
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
RFA-CA-25-003
Innovative Molecular Analysis Technologies (IMAT) Program
EDU NGO ENTERPRISE PUBLIC RESEARCH OTHER
US
HEALTHCARE OTHER
IDEA DEVELOPMENT
0-10 11-50 51-250 251-500 500+
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
1000000.00
150000.00
150000.00
USD
100.00
Oct. 3, 2025, 5 p.m.
March 2025 - July 2025